What Blood Test to Check Cancer? Screening Guide

The most direct answer to 'what blood test to check cancer' is that no single blood test can diagnose all cancers, but a combination of tumor markers, complete blood count (CBC), and liquid biopsy panels are used for screening and monitoring. Today, advancements in multi-cancer early detection (MCED) tests have expanded the options available. These tests analyze circulating tumor DNA (ctDNA), proteins, and other biomarkers to identify potential malignancies before symptoms appear. Understanding which blood test is appropriate depends on your risk factors, family history, and the specific cancer type being evaluated.

Understanding Cancer Blood Tests

Cancer blood tests are laboratory analyses that measure specific substances in your blood that may indicate the presence of cancer. They are not standalone diagnostic tools but are often used alongside imaging and biopsy for confirmation. The three main categories include:

• Tumor Marker Tests: Measure proteins or other substances produced by cancer cells (e.g., PSA for prostate cancer, CA-125 for ovarian cancer, CEA for colorectal cancer).
• Complete Blood Count (CBC): Evaluates overall blood cell health; abnormalities may suggest leukemia or lymphoma.
• Liquid Biopsy: Detects ctDNA fragments shed by tumors into the bloodstream, enabling early detection and mutation tracking.

Common Tumor Markers

Tumor markers are not definitive for cancer because non-cancerous conditions can also elevate them. Today, clinicians interpret these markers in conjunction with other tests. Examples include:

Complete Blood Count (CBC)

A CBC measures red blood cells, white blood cells, and platelets. Significant deviations from normal ranges can prompt further investigation for blood cancers like leukemia or lymphoma. For example, unexplained anemia or very high white cell counts may be red flags. Today, automated CBC analyzers also provide flags for immature cells, aiding early detection.

Liquid Biopsy

Liquid biopsy is a breakthrough in non-invasive cancer detection. It captures ctDNA and circulating tumor cells (CTCs) from a simple blood draw. Multi-cancer early detection tests (MCEDs) can screen for over 50 cancer types simultaneously, often with a single blood sample. The FDA has approved several MCED tests for clinical use Currently, though they are typically recommended for high-risk individuals.

Which Blood Tests Are Recommended for Cancer Screening?

Routine screening blood tests are recommended based on age, sex, and risk factors. The U.S. Preventive Services Task Force (USPSTF) and professional societies provide guidelines:

For Specific Cancer Types

• Prostate Cancer: PSA blood test (men aged 55–69, after shared decision-making).
• Ovarian Cancer: CA-125 (only for high-risk women, not general screening).
• Colorectal Cancer: CEA (used for monitoring, not initial screening).
• Liver Cancer: AFP (for chronic hepatitis B or cirrhosis patients).
• Multiple Cancers: MCED liquid biopsy (available for high-risk or symptomatic patients).

Limitations and Considerations

No blood test is 100% accurate. False positives can cause anxiety and unnecessary procedures, while false negatives may delay diagnosis. Today, the emphasis is on using blood tests as part of a comprehensive screening strategy that includes imaging, physical exams, and risk assessment. Always discuss results with a healthcare provider who can interpret them in context.

Frequently Asked Questions

Ready to take control of your health? Order a comprehensive cancer screening blood test from anylabtests.com. Our panels include tumor markers, CBC, and liquid biopsy options tailored to your needs. Visit /order/cancer-screening-panel to select the right test and get results from a CLIA-certified lab. Early detection saves lives—start your screening today.